InternetIntelligenz 2.0

kostenlos Pressemitteilungen einstellen | veröffentlichen | verteilen

Pressemitteilungen

 

Microplate Systems Market | Increasing R&D Expenditure in the Pharmaceutical Industry

ID: 1776900

The global microplate system market is expected to reach USD 996.9 Million by 2022 from USD 791.7 Million in 2016 at a CAGR of 4.0%.


(IINews) - The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases.

The report "Microplate Systems Market by Product (Microplate Reader (Multi-mode {Hybrid}, Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) - Forecast to 2022", is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017, at a CAGR of 4.0%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37081572

The microplate readers segment is expected to dominate the market in 2017

Based on product, the market is segmented into microplate readers, microplate pipetting systems and dispensers, microplate washers, and other products. In 2017, microplate readers segment is expected to account for the largest share of the microplate systems market as it is used in various applications such as investigation of new drug targets in the early stages of drug discovery as well as in research, bioassay validation, QC, and for the detection of biological, chemical, or physical processes in samples contained in microtiter plates.

Based on type, multi-mode microplate reader segment is expected to dominate the market in 2017

Based on type, microplate readers market is segmented into multi-mode microplate reader and single-mode microplate reader. The multi-mode microplate readers are expected to dominate the market in 2017. It is also expected to register the highest growth rate during the forecast period. The growth of this segment is attributed to the advantages associated with it such as increased throughput and efficiency.

The drug discovery segment is projected to grow at the highest CAGR during the forecast period.

Based on application, the market is segmented into drug discovery, clinical diagnostics, genomics and proteomics research, and other applications (cell biology, food testing, and environmental monitoring). The drug discovery segment is estimated to hold the largest share of the microplate systems market in 2017. It is expected to register the highest CAGR during the forecast period. The need for high-/ultra-high-throughput screening and reduced time-to-market for drugs are the major drivers for the growth of the drug discovery segment.





Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37081572

North America to dominate the microplate systems market

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to increasing government investments to support the development of advanced diagnostic procedures, technological advancements, increasing ageing population, easy accessibility and high adoption of advanced research and diagnostic technologies (due to the significant per capita annual healthcare expenditure by the government) and rising prevalence of chronic and infectious diseases. In 2017, Europe is expected to account for the second-largest share of this market. Rising government support for research and innovation and expanding biotechnology industry are the major factors supporting the growth of the microplate systems market in this regional segment.

The microplate systems market is fragmented, with the presence of several large as well as emerging players. Prominent players in the micropate systems market include Tecan (Switzerland), BioTek (US), Danaher (US), PerkinElmer (US), Thermo Fisher (US), BMG LABTECH (Germany), BERTHOLD (Germany), Agilent (US), Bio-Rad (US), Promega (US), Biochrom (UK), Corning (US), Lonza (Switzerland), Rayto (China), and Mindray (China). Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, and collaborations to widen their product portfolios and expand their presence in the market, globally.


Themen in diesem Fachartikel:


Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies'' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets''s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Leseranfragen:



PresseKontakt / Agentur:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com



drucken  als PDF  an Freund senden  Piramal Pharma Solutions verkündet Partnerschaft mit BerGenBio zur Entwicklung einer Leukämietherapie mit Fast-Track-Status der FDA
Precision For Medicine, Oncology and Rare Disease bei OBN Awards als bestes Spezial-Auftragsforschungsinstitut (CRO) ausgezeichnet
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 05.12.2019 - 09:41 Uhr
Sprache: Deutsch
News-ID 1776900
Anzahl Zeichen: 0

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook


Telefon: 18886006441

Kategorie:

Biotechnologie


Anmerkungen:


Dieser Fachartikel wurde bisher 256 mal aufgerufen.


Der Fachartikel mit dem Titel:
"Microplate Systems Market | Increasing R&D Expenditure in the Pharmaceutical Industry
"
steht unter der journalistisch-redaktionellen Verantwortung von

MnM (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MnM



 

Wer ist Online

Alle Mitglieder: 50.255
Registriert Heute: 0
Registriert Gestern: 0
Mitglied(er) online: 0
Gäste Online: 46


Bitte registrieren Sie sich hier. Als angemeldeter Benutzer nutzen Sie den vollen Funktionsumfang dieser Seite.